Search Results - "VAN KESTEREN, Charlotte"

Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation by Langenhorst, Jurgen B., Dorlo, Thomas P. C., van Maarseveen, Erik M., Nierkens, Stefan, Kuball, Jürgen, Boelens, Jaap Jan, van Kesteren, Charlotte, Huitema, Alwin D. R.

“…Background Fludarabine is often used as an important drug in reduced toxicity conditioning regimens prior to hematopoietic cell transplantation (HCT). As no…”
Get full text

Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review by Beex-Oosterhuis, Marieke M, Van Gool, Arthur R, Heerdink, Eibert R, van Kesteren, Charlotte, van Marum, Rob J

“…The objective of this systematic review was to provide a critical appraisal of the evidence related to the safety of clozapine for schizophrenia during…”
Get full text

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis by Admiraal, Rick, Nierkens, Stefan, de Witte, Moniek A, Petersen, Eefke J, Fleurke, Ger-jan, Verrest, Luka, Belitser, Svetlana V, Bredius, Robbert G M, Raymakers, Reinier A P, Knibbe, Catherijne A J, Minnema, Monique C, van Kesteren, Charlotte, Kuball, Jurgen, Boelens, Jaap J

“…Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can…”
Get full text

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome by Admiraal, Rick, Jol-van der Zijde, Cornelia M., Furtado Silva, Juliana M., Knibbe, Catherijne A. J., Lankester, Arjan C., Boelens, Jaap Jan, Hale, Goeff, Etuk, Aniekan, Wilson, Melanie, Adams, Stuart, Veys, Paul, van Kesteren, Charlotte, Bredius, Robbert G. M.

“…Background and Objective Alemtuzumab (Campath ® ) is used to prevent graft-versus-host disease and graft failure following pediatric allogeneic hematopoietic…”
Get full text

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis by Admiraal, Rick, MD, Nierkens, Stefan, PhD, de Witte, Moniek A, MD, Petersen, Eefke J, MD, Fleurke, Ger-jan, MD, Verrest, Luka, MSc, Belitser, Svetlana V, MSc, Bredius, Robbert G M, MD, Raymakers, Reinier A P, MD, Knibbe, Catherijne A J, Prof, Minnema, Monique C, MD, van Kesteren, Charlotte, PhD, Kuball, Jurgen, Prof, Boelens, Jaap J, Dr

“…Summary Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after allogeneic haemopoietic cell transplantation (HCT)…”
Get full text

Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis by Admiraal, Rick, MD, van Kesteren, Charlotte, PhD, Jol-van der Zijde, Cornelia M, BSc, Lankester, Arjan C, MD, Bierings, Marc B, MD, Egberts, Toine C G, Prof, van Tol, Maarten J D, PhD, Knibbe, Catherijne A J, Prof, Bredius, Robbert G M, MD, Boelens, Jaap J, Dr

“…Summary Background Anti-thymocyte globulin (ATG) was introduced into the conditioning regimen in haemopoietic cell transplantation (HCT) to prevent…”
Get full text

Population Pharmacokinetic Modeling of Thymoglobulin® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing by Admiraal, Rick, van Kesteren, Charlotte, Jol-van der Zijde, Cornelia M., van Tol, Maarten J. D., Bartelink, Imke H., Bredius, Robbert G. M., Boelens, Jaap Jan, Knibbe, Catherijne A. J.

“…Background and Objectives To prevent graft-versus-host disease and rejection in hematopoietic cell transplantation (HCT), children receive Thymoglobulin ® , a…”
Get full text

Antithymocyte globulin: Importance of good clinical pharmacological practice by Admiraal, Rick, MD, van Kesteren, Charlotte, PharmD, PhD, Nierkens, Stefan, PhD, Boelens, Jaap Jan, MD, PhD

“…Furthermore, the developed models are not validated, which is essential before deriving a new recommended dose. [...]technical issues need to be addressed…”
Get full text

Difference in decline in renal function due to cisplatin after a short or long hydration scheme in non–small‐cell lung cancer: A retrospective cohort study (HYCIS‐XL) by Niggebrugge‐Mentink, Kelly L., Beex‐Oosterhuis, Marieke M., Horst, Peter G. J., Poll, Matthijs E. C., Dieleman, Hetty G., Kesteren, Charlotte

“…What is known and objective Nephrotoxicity is a frequently occurring side effect of cisplatin, which may be reduced by applying ample hydration. The aim of…”
Get full text

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients by van Doorn, Leni, Crombag, Marie-Rose B S, Rier, Hánah N, van Vugt, Jeroen L A, van Kesteren, Charlotte, Bins, Sander, Mathijssen, Ron H J, Levin, Mark-David, Koolen, Stijn L W

“…Changes in body composition are associated with chemotherapy-related toxicities and effectiveness of treatment. It is hypothesized that the pharmacokinetics…”
Get full text

Predictive Performance of a Busulfan Pharmacokinetic Model in Children and Young Adults by BARTELINK, Imke H, KESTEREN, Charlotte Van, KNIBBE, Catherijne A. J, BOELENS, Jaap J, EGBERTS, Toine C. G, BIERINGS, Marc B, CUVELIER, Geoff D. E, WYNN, Robert F, SLATTER, Mary A, CHIESA, Robert, DANHOF, Meindert

“…Recently a pediatric pharmacokinetic (PK) model was developed for busulfan to explain the wide variability in PK of busulfan in children, as this variability…”
Get full text

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation by Langenhorst, Jurgen B., Dorlo, Thomas P.C., Kesteren, Charlotte, Maarseveen, Erik M., Nierkens, Stefan, Witte, Moniek A., Boelens, Jaap Jan, Huitema, Alwin D.R.

“…Optimal fludarabine exposure has been associated with improved treatment outcome in allogeneic hematopoietic cell transplantation, suggesting potential benefit…”
Get full text

Development of an optimal lidocaine infusion strategy for neonatal seizures by MALINGRE, Mirte M, VAN ROOIJ, Linda G. M, RADEMAKER, Carin M. A, TOET, Mona C, VERVERS, Tessa F. F. T, VAN KESTEREN, Charlotte, DE VRIES, Linda S

“…Lidocaine is an effective drug for the treatment of neonatal convulsions not responding to traditional anticonvulsant therapy. However, one of the side-effects…”
Get full text

A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies by Miguel A. Villalona-Calero, S. Gail Eckhardt, Geoffrey Weiss, Manuel Hidalgo, Jos H. Beijnen, Charlotte van Kesteren, Hilde Rosing, Elizabeth Campbell, Maura Kraynak, Luis Lopez-Lazaro, Cecilia Guzman, Daniel D. Von Hoff, Jose Jimeno, Eric K. Rowinsky

“…Purpose: The purpose of this study was to ( a ) assess the feasibility of administering ecteinascidin-743 (ET-743), a novel DNA minor-groove disrupting agent…”
Get full text

Pharmacokinetics and Pharmacodynamics of the Novel Marine-derived Anticancer Agent Ecteinascidin 743 in a Phase I Dose-finding Study by VAN KESTEREN, Charlotte, CVITKOVIC, Esteban, HILLEBRAND, Michael J. X, ROSING, Hilde, BEIJNEN, Jos H, TAAMMA, Adelkrim, LOPEZ-LAZARO, Luis, JIMENO, Jose M, GUZMAN, Cecilia, MATHOT, Ron A. A, SCHELLENS, Jan H. M, MISSET, Jean-Louis, BRAIN, Etienne

“…Ecteinascidin (ET) 743 is an anticancer agent derived from the Caribbean tunicate Ecteinascidia turbinata . Preclinical studies revealed activity of ET-743…”
Get full text

Patients with bariatric surgery: Urgent need for accurate registration of the contraindication to enable safe pharmacotherapy in hospital and primary care by Lau, Cedric, Sbaa, Ouarda, Smeenk, Robert, van Kesteren, Charlotte

“…Purpose To enable the use of automatic clinical decision support for pharmacotherapy in patients with bariatric surgery, it is necessary to register the…”
Get full text

Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation by Admiraal, Rick, Lindemans, Caroline A., van Kesteren, Charlotte, Bierings, Marc B., Versluijs, A. Birgitta, Nierkens, Stefan, Boelens, Jaap Jan

“…Successful immune reconstitution (IR) is associated with improved outcomes following pediatric cord blood transplantation (CBT). Usage and timing of…”
Get full text

Population pharmacokinetics of allopurinol in full-term neonates with perinatal asphyxia by VAN KESTEREN, Charlotte, BENDERS, Manon J. N. L, GROENENDAAL, Floris, VAN BEL, Frank, VERVERS, F. F. Tessa, RADEMAKER, Carin M. A

“…In newborn infants, allopurinol is being tested as a free radical scavenger to prevent brain damage caused by reperfusion and oxygenation after perinatal…”
Get full text

A Dutch Survey on Medication Adjustments after Metabolic and Bariatric Surgery: Experiences of Bariatric Surgeons, Internists, Pharmacists, and General Practitioners by Lau, Cedric, van Kesteren, Charlotte, Smeenk, Robert M.

“…Background As metabolic and bariatric surgery (MBS) can alter the pharmacokinetics of drugs, post-bariatric surgery patients may require medication adjustments…”
Get full text

Impact of Bariatric Surgery in the Short and Long Term: A Need for Time-Dependent Dosing of Drugs by Lau, Cedric, van Kesteren, Charlotte, Smeenk, Robert, Huitema, Alwin, Knibbe, Catherijne A. J.

“…Sparse information is available on pharmacokinetic changes of drugs over time after bariatric surgery. By reviewing the literature on the short- and long-term…”
Get full text